The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Microbiome Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Next Generation Sequencing
1.2.3 Polymerase Chain Reaction
1.3 Market by Application
1.3.1 Global Cancer Microbiome Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Microbiome Testing Market Perspective (2018-2029)
2.2 Cancer Microbiome Testing Growth Trends by Region
2.2.1 Global Cancer Microbiome Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cancer Microbiome Testing Historic Market Size by Region (2018-2023)
2.2.3 Cancer Microbiome Testing Forecasted Market Size by Region (2024-2029)
2.3 Cancer Microbiome Testing Market Dynamics
2.3.1 Cancer Microbiome Testing Industry Trends
2.3.2 Cancer Microbiome Testing Market Drivers
2.3.3 Cancer Microbiome Testing Market Challenges
2.3.4 Cancer Microbiome Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Microbiome Testing Players by Revenue
3.1.1 Global Top Cancer Microbiome Testing Players by Revenue (2018-2023)
3.1.2 Global Cancer Microbiome Testing Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Microbiome Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Microbiome Testing Revenue
3.4 Global Cancer Microbiome Testing Market Concentration Ratio
3.4.1 Global Cancer Microbiome Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Microbiome Testing Revenue in 2022
3.5 Cancer Microbiome Testing Key Players Head office and Area Served
3.6 Key Players Cancer Microbiome Testing Product Solution and Service
3.7 Date of Enter into Cancer Microbiome Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Microbiome Testing Breakdown Data by Type
4.1 Global Cancer Microbiome Testing Historic Market Size by Type (2018-2023)
4.2 Global Cancer Microbiome Testing Forecasted Market Size by Type (2024-2029)
5 Cancer Microbiome Testing Breakdown Data by Application
5.1 Global Cancer Microbiome Testing Historic Market Size by Application (2018-2023)
5.2 Global Cancer Microbiome Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cancer Microbiome Testing Market Size (2018-2029)
6.2 North America Cancer Microbiome Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cancer Microbiome Testing Market Size by Country (2018-2023)
6.4 North America Cancer Microbiome Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Microbiome Testing Market Size (2018-2029)
7.2 Europe Cancer Microbiome Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cancer Microbiome Testing Market Size by Country (2018-2023)
7.4 Europe Cancer Microbiome Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Microbiome Testing Market Size (2018-2029)
8.2 Asia-Pacific Cancer Microbiome Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cancer Microbiome Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Cancer Microbiome Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Microbiome Testing Market Size (2018-2029)
9.2 Latin America Cancer Microbiome Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cancer Microbiome Testing Market Size by Country (2018-2023)
9.4 Latin America Cancer Microbiome Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Microbiome Testing Market Size (2018-2029)
10.2 Middle East & Africa Cancer Microbiome Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cancer Microbiome Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Cancer Microbiome Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CD Genomics
11.1.1 CD Genomics Company Detail
11.1.2 CD Genomics Business Overview
11.1.3 CD Genomics Cancer Microbiome Testing Introduction
11.1.4 CD Genomics Revenue in Cancer Microbiome Testing Business (2018-2023)
11.1.5 CD Genomics Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Detail
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Cancer Microbiome Testing Introduction
11.2.4 Eurofins Scientific Revenue in Cancer Microbiome Testing Business (2018-2023)
11.2.5 Eurofins Scientific Recent Development
11.3 Illumina
11.3.1 Illumina Company Detail
11.3.2 Illumina Business Overview
11.3.3 Illumina Cancer Microbiome Testing Introduction
11.3.4 Illumina Revenue in Cancer Microbiome Testing Business (2018-2023)
11.3.5 Illumina Recent Development
11.4 Prescient Medicine Holding
11.4.1 Prescient Medicine Holding Company Detail
11.4.2 Prescient Medicine Holding Business Overview
11.4.3 Prescient Medicine Holding Cancer Microbiome Testing Introduction
11.4.4 Prescient Medicine Holding Revenue in Cancer Microbiome Testing Business (2018-2023)
11.4.5 Prescient Medicine Holding Recent Development
11.5 Micronoma
11.5.1 Micronoma Company Detail
11.5.2 Micronoma Business Overview
11.5.3 Micronoma Cancer Microbiome Testing Introduction
11.5.4 Micronoma Revenue in Cancer Microbiome Testing Business (2018-2023)
11.5.5 Micronoma Recent Development
11.6 Novogene
11.6.1 Novogene Company Detail
11.6.2 Novogene Business Overview
11.6.3 Novogene Cancer Microbiome Testing Introduction
11.6.4 Novogene Revenue in Cancer Microbiome Testing Business (2018-2023)
11.6.5 Novogene Recent Development
11.7 Oxford Nanopore Technologies
11.7.1 Oxford Nanopore Technologies Company Detail
11.7.2 Oxford Nanopore Technologies Business Overview
11.7.3 Oxford Nanopore Technologies Cancer Microbiome Testing Introduction
11.7.4 Oxford Nanopore Technologies Revenue in Cancer Microbiome Testing Business (2018-2023)
11.7.5 Oxford Nanopore Technologies Recent Development
11.8 Pacific Biosciences
11.8.1 Pacific Biosciences Company Detail
11.8.2 Pacific Biosciences Business Overview
11.8.3 Pacific Biosciences Cancer Microbiome Testing Introduction
11.8.4 Pacific Biosciences Revenue in Cancer Microbiome Testing Business (2018-2023)
11.8.5 Pacific Biosciences Recent Development
11.9 Qiagen
11.9.1 Qiagen Company Detail
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Cancer Microbiome Testing Introduction
11.9.4 Qiagen Revenue in Cancer Microbiome Testing Business (2018-2023)
11.9.5 Qiagen Recent Development
11.10 Therma Fisher Scientific
11.10.1 Therma Fisher Scientific Company Detail
11.10.2 Therma Fisher Scientific Business Overview
11.10.3 Therma Fisher Scientific Cancer Microbiome Testing Introduction
11.10.4 Therma Fisher Scientific Revenue in Cancer Microbiome Testing Business (2018-2023)
11.10.5 Therma Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details